|
521 |
Reporting quality of randomized controlled trials in patients with HIV on antiretroviral therapy: a systematic review
Enthalten in Trials Bd. 18, 28.12.2017, Nr. 1, date:12.2017: 1-12
|
|
|
|
522 |
Research Involvement and Engagement: reflections so far and future directions
Enthalten in Research involvement and engagement Bd. 3, 8.11.2017, Nr. 1, date:12.2017: 1-6
|
|
|
|
523 |
Research Professionals’ Perspectives, Barriers, and Recommendations Regarding Minority Participation in Clinical Trials
Enthalten in Journal of racial and ethnic health disparities Bd. 4, 21.12.2016, Nr. 6, date:12.2017: 1166-1174
|
|
|
|
524 |
Research waste in diagnostic trials: a methods review evaluating the reporting of test-treatment interventions
Enthalten in BMC medical research methodology Bd. 17, 24.2.2017, Nr. 1, date:12.2017: 1-13
|
|
|
|
525 |
Response to letter to editor: ‘Comment on Arch et al., Trials. 2016;17:517’
Enthalten in Trials Bd. 18, 26.5.2017, Nr. 1, date:12.2017: 1-4
|
|
|
|
526 |
Resveratrol alleviates inflammatory hyperalgesia by modulation of reactive oxygen species (ROS), antioxidant enzymes and ERK activation
Enthalten in Inflammation research Bd. 66, 24.6.2017, Nr. 10, date:10.2017: 911-921
|
|
|
|
527 |
Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer’s disease
Enthalten in Journal of neuroinflammation Bd. 14, 3.1.2017, Nr. 1, date:12.2017: 1-10
|
|
|
|
528 |
Review and publication of protocol submissions to Trials – what have we learned in 10 years?
Enthalten in Trials Bd. 18, 16.12.2016, Nr. 1, date:12.2017: 1-5
|
|
|
|
529 |
Review of Post-Marketing Safety Data on Tapentadol, a Centrally Acting Analgesic
Enthalten in Advances in therapy Bd. 35, 21.12.2017, Nr. 1, date:1.2018: 12-30
|
|
|
|
530 |
Risk Perceptions in Diabetic Patients Who Have Experienced Adverse Events: Implications for Patient Involvement in Regulatory Decisions
Enthalten in Pharmaceutical medicine Bd. 31, 18.7.2017, Nr. 4, date:8.2017: 245-255
|
|
Administration
